EUCRW

Eucrates Biomedical Acquisition Corp. Warrant
EUCRW

Overview Fund Activity
Delisted

EUCRW was delisted on the 26th of April, 2023.

Back to rankings

25 hedge funds and large institutions have $1.08M invested in Eucrates Biomedical Acquisition Corp. Warrant in 2022 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 4 closing their positions.

Holders
25
Holders Change
+1
Holders Change %
+4.17%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
2
Reduced
4
Closed
4
Calls
$1K
Puts
–
Net Calls
+$1K
Net Calls Change
–

Top Buyers

1
CIM
1
Cowen Investment Management
New York
$1.85K
2
SIA
2
Schechter Investment Advisors
Michigan
$1.45K
3
RCM
3
Rivernorth Capital Management
Florida
$2.93K
4
HIM
4
HGC Investment Management
Ontario, Canada
$1K
5
OMC
5
Old Mission Capital
Illinois
$891

Top Sellers

1
Goldman Sachs
1
Goldman Sachs
New York
$1.39K
2
BlackRock
2
BlackRock
New York
$0
3
MF
3
Magnetar Financial
Illinois
$0
4
CH
4
CVI Holdings
Delaware
$3.78K
5
Hudson Bay Capital Management
5
Hudson Bay Capital Management
Connecticut
$0
Name Market Value Shares Shares
Change 		Shares
Change %
MF
26
Magnetar Financial
Illinois
– – -130,665 Closed
Hudson Bay Capital Management
27
Hudson Bay Capital Management
Connecticut
– – -24,536 Closed
GCL
28
Glazer Capital LLC
New York
– – -11,584 Closed
AA
29
Ancora Advisors
Ohio
$0 47 – –
Millennium Management
30
Millennium Management
New York
– – – –
CFGS
31
Concourse Financial Group Securities
Alabama
– – – –
1
2